Components of the metabolic syndrome and carotid atherosclerosis role of elevated blood pressure

被引:44
作者
Irace, C
Cortese, C
Fiaschi, E
Carallo, C
Sesti, G
Farinaro, E
Gnasso, A
机构
[1] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin G Salvatore, Catanzaro, Italy
[2] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy
[3] Univ Naples Federico II, Dipartimento Sci Med & Prevent, Naples, Italy
关键词
atherosclerosis; carotid arteries; hypertension;
D O I
10.1161/01.HYP.0000158945.52283.c2
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Elevated blood pressure is among the factors that contribute to the metabolic syndrome (MetS). It is not known whether subjects with MetS and elevated blood pressure are at the same cardiovascular risk as subjects with MetS but without elevated blood pressure. To clarify this point, we have evaluated the prevalence of carotid atherosclerosis in subjects with MetS with or without elevated blood pressure. A large population was examined ( 842 women and 1011 men). Blood pressure, lipids, glucose, and waist were measured by routine methods. Carotid atherosclerosis was evaluated by echo Doppler examination. The prevalence of MetS was 24.4% in women and 28.7% in men. The prevalence of carotid atherosclerosis was 35.1% in women and 37.3% in men (p=NS), and increased with increasing number of MetS components. Age, smoking, and systolic blood pressure (SBP) were associated with the presence of carotid atherosclerosis ( logistic model), whereas age, high-density lipoprotein cholesterol, and SBP were associated with the extent of atherosclerosis ( linear model). When comparing subjects with an equal number of MetS components, the prevalence of carotid atherosclerosis was significantly higher in subjects with elevated blood pressure than in those without. No difference in carotid atherosclerosis prevalence was found in subjects bearing or not bearing components of the syndrome other than elevated blood pressure. The present findings demonstrate that subjects with MetS and elevated blood pressure have increased carotid atherosclerosis compared with subjects with MetS but without elevated blood pressure. The diagnosis of MetS per se might not adequately identify subjects at elevated cardiovascular risk.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 25 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]   Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease [J].
Anand, SS ;
Yi, QL ;
Gerstein, H ;
Lonn, E ;
Jacobs, R ;
Vuksan, V ;
Teo, K ;
Davis, B ;
Montague, P ;
Yusuf, S .
CIRCULATION, 2003, 108 (04) :420-425
[3]   Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease? [J].
Anderson, JL ;
Horne, BD ;
Jones, HU ;
Reyna, SP ;
Carlquist, JF ;
Bair, TL ;
Pearson, RR ;
Lappé, DL ;
Muhlestein, JB .
CARDIOLOGY, 2004, 101 (04) :185-193
[4]   Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study [J].
Bonora, E ;
Kiechl, S ;
Willeit, J ;
Oberhollenzer, F ;
Egger, G ;
Bonadonna, RC ;
Muggeo, M .
INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (10) :1283-1289
[5]   Risk factors for progression of common carotid atherosclerosis: The atherosclerosis risk in communities study, 1987-1998 [J].
Chambless, LE ;
Folsom, AR ;
Davis, V ;
Sharrett, R ;
Heiss, G ;
Sorlie, P ;
Szklo, M ;
Howard, G ;
Evans, GW .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (01) :38-47
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[8]   The metabolic syndrome and risk of major coronary events in the Scandinavian simvastatin survival study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) [J].
Girman, CJ ;
Rhodes, T ;
Mercuri, M ;
Pyörälä, K ;
Kjekshus, J ;
Pedersen, TR ;
Beere, PA ;
Gotto, AM ;
Clearfield, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02) :136-141
[9]   In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis [J].
Gnasso, A ;
Irace, C ;
Carallo, C ;
DeFranceschi, MS ;
Motti, C ;
Mattioli, PL ;
Pujia, A .
STROKE, 1997, 28 (05) :993-998
[10]   Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy [J].
Gnasso, A ;
Calindro, MC ;
Carallo, C ;
DeNovara, G ;
Ferraro, M ;
Gorgone, G ;
Irace, C ;
Romeo, P ;
Siclari, D ;
Spagnuolo, V ;
Talarico, R ;
Mattioli, PL ;
Pujia, A .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1997, 13 (04) :421-428